Blood banking is the process that takes place in the lab to make sure that donated blood, or blood products, are safe before they are used in blood transfusions and other medical procedures. Blood banking includes typing the blood for transfusion and testing for infectious diseases. According to the American Association of Blood Banks as of 2013: About 36,000 units of blood are needed every
day. The number of blood units donated is about 13.6 million a year. About 6.8 million volunteers are blood donors each year. Each unit of blood is broken down into components, such as red blood cells, plasma, cryoprecipitated AHF, and platelets. One unit of whole blood, once it's separated, may be transfused to several patients, each with different needs. Annually, more than 21 million blood components are transfused. Most blood donors are volunteers. However, sometimes, a patient may want to donate blood a couple of weeks before undergoing surgery, so that his or her blood is available in case of a blood transfusion. Donating blood for yourself is called an autologous donation. Volunteer blood donors must pass certain criteria, including the following: Must be at least 16 years of age, or in accordance with state law Must be in good health Must weigh at least 110 pounds Must pass the physical and health history exam given before donation Some states permit people younger than 16 or 17 years to donate blood, with parental consent. What tests are done in blood banking?A certain set of standard tests are done in the lab once blood is donated, including, but not limited to, the following:
What are the blood types?According to the American Association of Blood Banks, distribution of blood types in the U.S. includes the following:
What are the components of blood?While blood, or one of its components, may be transferred, each component serves many functions, including the following:
Albumin, immune globulins, and clotting factor concentrates may also be separated and processed for transfusions. Rule 111-8-10-.01 Legal AuthorityThe legal authority for this chapter is found in Chapters 2, 7 and 22 of Title 31 of the Official Code of Georgia Annotated. Rule 111-8-10-.02 PurposeThe purpose of these rules is to implement the requirements of Chapter 22 of Title 31 of the Official Code of Georgia Annotated pertaining to the licensure of clinical laboratories and the qualifications and performances of laboratory personnel. Rule 111-8-10-.03 DefinitionsUnless a different meaning is required by the context, the following terms as used in these rules and regulations shall have the meaning here in after respectively ascribed to them:
Rule 111-8-10-.04 License
Rule 111-8-10-.05 Fees
Rule 111-8-10-.06 Laboratory Personnel Requirements, Personnel Qualifications and Personnel Records
Rule 111-8-10-.07 Application
Rule 111-8-10-.08 Sanitation and Safety
Rule 111-8-10-.09 General Quality Control RequirementsEach laboratory shall establish and follow written policies and procedures for a quality assurance program, comprehensive in scope and specific to that laboratory. The program shall monitor and evaluate the ongoing and overall quality of the total testing process from specimen collection to reporting of test results. The program shall identify and correct problems, assure the accurate, reliable and prompt reporting of test results and assure adequacy and competency of laboratory staff. Written procedures shall be revised when evaluation results indicate the need. There must be documentation of the ongoing quality assurance program as well as corrective action taken when necessary. The laboratory director is responsible for ensuring that the following quality controls are employed for all clinical testing authorized under the laboratory's license:
Rule 111-8-10-.10 Quality Control for MicrobiologyChemical or biological solutions, reagents, and antiserum shall be tested and inspected as prescribed by the Department for reactivity and deterioration. Discs and systems used in antibiotic susceptibility testing are checked for deterioration and proper reactivity, using approved reference organisms.
Rule 111-8-10-.11 Quality Control for Serology/Immunology
Rule 111-8-10-.12 Quality Control for Clinical Chemistry
Rule 111-8-10-.13 Quality Control for ImmunohematologyThose clinical laboratories which provide for the collection, processing or storage of human blood and its components shall provide methods for the selection of blood and component donors as well as for the collection, storage, processing and transfusion of blood and its components, and shall ensure that the blood and component donation will not be detrimental to the donor and also protect, as far as possible, the recipient of the human blood or any of its components from infectious disease known to be transmissible by blood. The methods used shall conform to the following:
Rule 111-8-10-.14 Quality Control for HematologyInstruments used in hematological examination of specimens shall be recalibrated, retested or reinspected, as appropriate, each day of use. Each procedure shall be recalibrated or rechecked each shift of use with standards or controls covering the entire range of expected values, unless required more frequently by the manufacturer or federal laboratory regulations. Tests such as the hematocrit and one-stage prothrombin time test shall be run in duplicate except as specified in published guidelines. Standard deviation, coefficient of variation, or other statistical estimates of precision shall be determined by the laboratory. All control materials used to satisfy the control requirement must have documented established limits. Rule 111-8-10-.15 Quality Control for Exfoliative Cytology; Histopathology; and oral Pathology
Rule 111-8-10-.16 Quality Control for Tissue BanksTissue banks which procure, store, or process human or animal tissue designed to be used for medical purposes in human beings shall conform to the procurement, storage and processing requirements listed in this section. The tissue bank must maintain donor and patient recipient records and communications. These records must be retained for not less than seven years after the distribution of the tissue material. These records shall be evaluated and reviewed by the director to ensure the suitability of the donated tissue for its intended use. Records must include the following:
Rule 111-8-10-.17 Quality Control for Sperm Banks/Embryology and Assisted Reproductive Technology (ART)
Rule 111-8-10-.18 Quality Control for Specimen Collection Stations
Rule 111-8-10-.19 Quality Control for Cytogenetics
Rule 111-8-10-.20 Quality Control for Screening and Monitoring Tests
Rule 111-8-10-.21 Quality Control for Histocompatibility
Rule 111-8-10-.22 Quality Control for Flow Cytometry
Rule 111-8-10-.23 EvaluationThe Department shall conduct a clinical laboratory performance evaluation (proficiency testing) program with the following requirements:
Rule 111-8-10-.24 Specimens Examined
Rule 111-8-10-.25 ReportingThe results of a test performed by a licensed clinical laboratory shall be reported only to (or as directed by) a licensed physician, dentist, or other authorized person requesting the test. Such reports shall include the name of the director and the name and street address of the clinical laboratory in which the test was performed. When a test is performed in a reference laboratory, the director, name and address of the laboratory performing the test must be clearly identified in the report. Rule 111-8-10-.26 RecordsRecords of all clinical laboratory services, including records of laboratory test requests and reports, shall be retained by the laboratory for as long as required by federal law and regulations, and:
Rule 111-8-10-.27 Reports to the Department
Rule 111-8-10-.28 Plasmapheresis and Whole Blood Donor CentersClinical laboratories, including independent plasmapheresis and whole blood donor centers, which provide a system for the collection, processing or storage of human blood and/or its components shall provide methods for the selection of donors as well as methods for the collection, storage, processing, and transfusion, which shall ensure that the donation will not be detrimental to the donor and also protect (as far as possible) the recipient of human blood or any of its components from infectious disease known to be transmissible by blood.
Rule 111-8-10-.29 Exemption of Specific Screening and Monitoring TestsA facility or part of a facility in which laboratory testing is performed may apply and qualify for exemption from personnel requirements for specific screening and monitoring tests or techniques, as approved and published by the Board.
Rule 111-8-10-.30 Inspection and Plans of Correction
Rule 111-8-10-.31 ExemptionsThese rules and regulations shall not apply to:
Rule 111-8-10-.32 Variances and WaiversThe Department, upon application or petition, may grant variances and waivers to these rules and regulations (after review and advice of Laboratory Advisory Council) when it is shown that the rule and regulation should not be applied as written, because strict application would cause undue hardship and that adequate standards affording protection of health, safety and care exist and will be met in lieu of the exact requirements, or that the purpose of the rule is met through equivalent standards affording equivalent protection of health, safety and care, or to allow experimentation or demonstration of new and innovative approaches to delivery of services, where the approach has the potential to improve service delivery and the intended protections afforded by the rule are being met. Rule 111-8-10-.33 Enforcement
Rule 111-8-10-.34 SeverabilityIn the event that any rule, sentence, clause or phrase of any of these rules and regulations may be construed by any court of competent jurisdiction to be invalid, illegal, unconstitutional, or otherwise unenforceable, such determination or adjudication shall in no manner affect the remaining rules or portions thereof and such remaining rules or portions thereof shall remain in full force and effect, as if such rule or portions thereof so determined, declared or adjudged invalid or unconstitutional were not originally a part thereof. What is the recommended blood culture site skin disinfectant for infants 2 months and older?Use 70% isopropyl alcohol as a disinfectant to the venipuncture site.
What would you measure with a noninvasive transcutaneous method?Transcutaneous monitoring is a noninvasive method to continuously measure the partial pressures of oxygen and carbon dioxide that diffuse through the skin and correlate closely with changes in blood gases.
What type of samples are not recommended to be sent in a pneumatic tube?Heavy specimens are NOT to be sent in the tube system. pneumatic tube system with one exception; blood culture bottles.
Which condition is a unit of blood withdrawn from a patient as treatment?Therapeutic phlebotomy is used to treat people with: Hemochromatosis. Polycythemia vera. Porphyria cutanea tarda.
|